Xia, Bo http://orcid.org/0000-0003-0929-7253
Zhang, Weimin http://orcid.org/0000-0002-8836-1438
Zhao, Guisheng
Zhang, Xinru http://orcid.org/0000-0002-0633-2888
Bai, Jiangshan
Brosh, Ran http://orcid.org/0000-0001-9714-8623
Wudzinska, Aleksandra http://orcid.org/0000-0002-3143-7673
Huang, Emily
Ashe, Hannah
Ellis, Gwen
Pour, Maayan
Zhao, Yu http://orcid.org/0000-0003-4659-9832
Coelho, Camila
Zhu, Yinan
Miller, Alexander
Dasen, Jeremy S.
Maurano, Matthew T. http://orcid.org/0000-0002-2218-8628
Kim, Sang Y.
Boeke, Jef D. http://orcid.org/0000-0001-5322-4946
Yanai, Itai http://orcid.org/0000-0002-8438-2741
Article History
Received: 14 September 2021
Accepted: 19 January 2024
First Online: 28 February 2024
Competing interests
: J.D.B. is a Founder and Director of CDI Labs, a Founder of and consultant to Neochromosome, a Founder, Scientific Advisory Board member of and consultant to ReOpen Diagnostics and serves or served on the Scientific Advisory Board of the following: Logomix, Modern Meadow, Rome Therapeutics, Sample6, Sangamo, Tessera Therapeutics and the Wyss Institute, all unrelated to the present work. The other authors declare no competing interests.